Concepedia

Aimin Tan

AT

Statistics

Publications

7

Citations

226

H-Index

7

Active since

2003

Affiliations

Simcere Pharmaceutical (China)(Current)

Nanjing University of Chinese Medicine

Nanjing Tech University

Aimin Tan is an author at Simcere Pharmaceutical (China) specializing in oncology, pharmacology, and medicine.

Publications per year

2003–2021

7

Publications

7

Patient-derived xenograft in zebrafish embryos: a new platform for translational research in gastric cancer

Jiaqi Wu, Jing Zhai, Chong-Yong Li et al. · Journal of Experimental & Clinical Cancer Research · 2017 · 96 citations · Full text

, , +15

Five new C21 steroidal glycosides from the stems of Marsdenia tenacissima

Hua Zhang, Aimin Tan, Zhang An-yuan et al. · Steroids · 2009 · 43 citations

, , +9

Phase I trial of veliparib, (ABT-888), a poly(ADP-ribose) polymerase (PARP) inhibitor, in combination with doxorubicin and cyclophosphamide in breast cancer and other solid tumors.

Aimin Tan, D. Toppmeyer, Mark N. Stein et al. · Journal of Clinical Oncology · 2011 · 35 citations

, , +14

New Pyrrolizidine Alkaloids from Ligularia tsangchanensis

Zhengtao Wang, Aimin Tan, Zhengtao Wang et al. · Heterocycles · 2003 · 17 citations · Full text

, , +7

Preliminary results of a phase I trial of ABT-888, a poly(ADP-ribose) polymerase (PARP) inhibitor, in combination with cyclophosphamide.

Aimin Tan, Darlene Gibbon, Mark N. Stein et al. · Journal of Clinical Oncology · 2010 · 13 citations

, , +14

1–5 of 7